Key result
Among older patients requiring ventricular pacing without a class I CRT indication, CRT-D was associated with lower 1-year mortality compared with DC-ICD (HR 0.70; 95% CI 0.57-0.87; P=0.001).
Why the study?
In patients with reduced LVEF requiring frequent RV pacing, the clinical practice patterns of CRT versus DC device use and associated outcomes were unknown in those without a class I CRT indication.
Does implantation of a CRT-D improve 1-year mortality and heart failure hospitalization compared to a DC-ICD in older patients requiring ventricular pacing who do not have a class I indication for CRT?
Population
3100 Medicare beneficiaries undergoing first-time CRT-D or DC-ICD implantation requiring ventricular pacing without class I CRT indication
Comparison
CRT-D vs DC-ICD implantation
Design
Retrospective cohort study
Follow-up
1-year
Authors
Loading...
In older patients requiring ventricular pacing without a class I indication for CRT, CRT-D implantation is associated with significantly lower 1-year mortality and heart failure hospitalization compared to DC-ICD.
Cohort (n=3,100)
Yes
Does implantation of a CRT-D improve 1-year mortality and heart failure hospitalization compared to a DC-ICD in older patients requiring ventricular pacing who do not have a class I indication for CRT?
Hazard Ratio: 0.7 (95% CI 0.57–0.87)
p-value: p=0.001
In older patients requiring ventricular pacing without a class I indication for CRT, CRT-D implantation is associated with significantly lower 1-year mortality and heart failure hospitalization compared to DC-ICD.
Borne et al. (2021) conducted a cohort in Ventricular bradycardia pacing indication without a class I indication for CRT (n=3,100). Cardiac resynchronization therapy defibrillator (CRT-D) vs. Dual chamber implantable cardioverter defibrillator (DC-ICD) was evaluated on 1-year all-cause mortality (HR 0.70, 95% CI 0.57-0.87, p=0.001). Among older patients requiring ventricular pacing without a class I CRT indication, CRT-D was associated with lower 1-year mortality compared with DC-ICD (HR 0.70; 95% CI 0.57-0.87; P=0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: